The Ensign Group, Inc.
ENSG Healthcare Medical Care Facilities
The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024.
- Revenue
- +14.5%
- EPS
- +23.6%
- Free cash flow
- +89.2%
- Total debt
- +39.2%
Quarter to September 2026, against a year earlier
Follow ENSG
Alert me
The Ensign Group, Inc. (ENSG) EV/Sales
As of 5 November 2026, The Ensign Group, Inc. (ENSG) trades at a EV/Sales of 1.8×. Over the past ten years it has ranged from 0.6× (November 2016) to 2.4× (March 2026); the current reading is higher than 84% of that period. That is above the Medical Care Facilities industry median of 1.4× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.9× | 12.60% |
| FY2024 | 1.7× | 4.09% |
| FY2023 | 1.6× | (2.66%) |
| FY2022 | 1.7× | (2.37%) |
| FY2021 | 1.7× | 8.30% |
| FY2020 | 1.6× | 19.15% |
| FY2019 | 1.3× | 11.12% |
| FY2018 | 1.2× | 39.13% |
| FY2017 | 0.9× | 11.30% |
| FY2016 | 0.8× | (8.60%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 1.7× | 3.52% |
| Jun 2026 | 1.7× | (21.72%) |
| Mar 2026 | 2.1× | 12.31% |
| Dec 2025 | 1.9× | (4.50%) |
| 43 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | 0.9× |
| UHS Universal Health Services, Inc. compare | 0.9× |
| PACS PACS Group, Inc. compare | 1.4× |
| DVA DaVita Inc. compare | 1.6× |
| ENSG The Ensign Group, Inc. | 1.8× |
| EHC Encompass Health Corporation compare | 2.6× |
| CHE Chemed Corporation compare | 2.7× |
| CON Concentra Group Holdings Parent, Inc. compare | 2.9× |
| LFST LifeStance Health Group, Inc. compare | 3.1× |
| Medical Care Facilities industry median | 1.4× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on ENSG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement